Systemic corticosteroids for management of COVID-19: Saving lives or causing harm?

1. Huang, C, Wang, Y, Li, X, et al. (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet 395(10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5.
Google Scholar | Crossref | Medline2. World Health Organization (2020) WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19 - 11 March 2020. Geneva, Switzerland: World Health Organization. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (Accessed 30 March 2020.
Google Scholar3. Yang, X, Yu, Y, Xu, J, et al. (2020) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 8(5): 475–481. DOI: 10.1016/S2213-2600(20)30079-5.
Google Scholar | Crossref | Medline4. Li, Q, Guan, X, Wu, P, et al. (2020) Early transmission dynamics in Wuhan, China, of Novel coronavirus-infected pneumonia. New England Journal of Medicine 382(13): 1199–1207. DOI: 10.1056/NEJMoa2001316.
Google Scholar | Crossref | Medline5. Fauci, AS, Lane, HC, Redfield, RR (2020) Covid-19 - navigating the uncharted. New England Journal of Medicine 382(13): 1268–1269. DOI: 10.1056/NEJMe2002387.
Google Scholar | Crossref | Medline6. Wang, D, Hu, B, Hu, C, et al. (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 323(11): 1061–1069. DOI: 10.1001/jama.2020.1585.
Google Scholar | Crossref | Medline7. Cao, J, Hu, X, Cheng, W, et al. (2020) Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intensive Care Medicine 46: 851–853. DOI: 10.1007/s00134-020-05987-7.
Google Scholar | Crossref | Medline8. Cao, J, Tu, W-J, Cheng, W, et al. (2020) Clinical features and short-term outcomes of 102 patients with coronavirus disease 2019 in Wuhan, China. Clinical Infectious Diseases 71: 748–755. DOI: 10.1093/cid/ciaa243.
Google Scholar | Crossref | Medline9. Garg, S, Kim, L, Whitaker, M, et al. (2020) Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR. Morbidity and Mortality Weekly Report 69(15): 458–464. DOI: 10.15585/mmwr.mm6915e3.
Google Scholar | Crossref | Medline10. Lauer, SA, Grantz, KH, Bi, Q, et al. (2020) The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of Internal Medicine 172: 577–582. DOI: 10.7326/M20-0504.
Google Scholar | Crossref | Medline11. Zhou, F, Yu, T, Du, R, et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395(10229): 1054–1062. DOI: 10.1016/S0140-6736(20)30566-3.
Google Scholar | Crossref | Medline12. Qin, C, Zhou, L, Hu, Z, et al. (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases 71: 762–768. DOI: 10.1093/cid/ciaa248.
Google Scholar | Crossref | Medline13. Zhang, C, Wu, Z, Li, J-W, et al. (2020) Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. International Journal of Antimicrobial Agents 55: 105954. DOI: 10.1016/j.ijantimicag.2020.105954.
Google Scholar | Crossref | Medline14. Wu, C, Chen, X, Cai, Y, et al. (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine 180(7): 934–943. DOI: 10.1001/jamainternmed.2020.0994.
Google Scholar | Crossref | Medline15. Tisoncik, JR, Korth, MJ, Simmons, CP, et al. (2012) Into the eye of the cytokine storm. Microbiology and Molecular Biology Reviews 76(1): 16–32. DOI: 10.1128/MMBR.05015-11.
Google Scholar | Crossref | Medline | ISI16. Lew, TWK, Kwek, T-K, Tai, D, et al. (2003) Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA 290(3): 374–380. DOI: 10.1001/jama.290.3.374.
Google Scholar | Crossref | Medline17. Kim, ES, Choe, PG, Park, WB, et al. (2016) Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection. Journal of Korean Medical Science 31(11): 1717–1725. DOI: 10.3346/jkms.2016.31.11.1717.
Google Scholar | Crossref | Medline18. Rhen, T, Cidlowski, JA (2005) Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. New England Journal of Medicine 353(16): 1711–1723. DOI: 10.1056/NEJMra050541.
Google Scholar | Crossref | Medline | ISI19. Brattsand, R, Linden, M (1996) Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Alimentary Pharmacology & Therapeutics 10(Suppl 2): 81–90. discussion 91-82. DOI: 10.1046/j.1365-2036.1996.22164025.x.
Google Scholar | Crossref | Medline | ISI20. Ye, Z, Wang, Y, Colunga-Lozano, LE, et al. (2020) Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. Canadian Medical Association Journal 192(27): E756–E767. DOI: 10.1503/cmaj.200645.
Google Scholar | Crossref21. Ewald, H, Raatz, H, Boscacci, R, et al. (2015) Adjunctive corticosteroids for pneumocystis jiroveci pneumonia in patients with HIV infection. Cochrane Database of Systematic Reviews 2015(4): CD006150. DOI: 10.1002/14651858.CD006150.pub2.
Google Scholar | Crossref22. Li, H, Chen, C, Hu, F, et al. (2020) Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis. Leukemia 34(6): 1503–1511. DOI: 10.1038/s41375-020-0848-3.
Google Scholar | Crossref | Medline23. Thompson, BT, Chambers, RC, Liu, KD (2017) Acute respiratory distress syndrome. New England Journal of Medicine 377(6): 562–572. DOI: 10.1056/NEJMra1608077.
Google Scholar | Crossref | Medline24. Annane, D, Pastores, SM, Rochwerg, B, et al. (2017) Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of critical care medicine (SCCM) and European society of intensive care medicine (ESICM) 2017. Critical Care Medicine 45(12): 2078–2088. DOI: 10.1097/CCM.0000000000002737.
Google Scholar | Crossref | Medline25. Bernard, GR, Luce, JM, Sprung, CL, et al. (1987) High-dose corticosteroids in patients with the adult respiratory distress syndrome. New England Journal of Medicine 317(25): 1565–1570. DOI: 10.1056/NEJM198712173172504.
Google Scholar | Crossref | Medline26. Meduri, GU, Headley, AS, Golden, E, et al. (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280(2): 159–165. DOI: 10.1001/jama.280.2.159.
Google Scholar | Crossref | Medline | ISI27. Confalonieri, M, Urbino, R, Potena, A, et al. (2005) Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. American Journal of Respiratory and Critical Care Medicine 171(3): 242–248. DOI: 10.1164/rccm.200406-808OC.
Google Scholar | Crossref | Medline28. Annane, D, Sébille, V, Bellissant, E, et al. (2006) Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome. Critical Care Medicine 34(1): 22–30. DOI: 10.1097/01.ccm.0000194723.78632.62.
Google Scholar | Crossref | Medline29. Steinberg, KP, Hudson, LD, Goodman, RB, et al. (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. New England Journal of Medicine 354(16): 1671–1684. DOI: 10.1056/NEJMoa051693.
Google Scholar | Crossref | Medline | ISI30. Meduri, GU, Golden, E, Freire, AX, et al. (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131(4): 954–963. DOI: 10.1378/chest.06-2100.
Google Scholar | Crossref | Medline | ISI31. Tongyoo, S, Permpikul, C, Mongkolpun, W, et al. (2016) Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Critical Care 20(1): 329. DOI: 10.1186/s13054-016-1511-2.
Google Scholar | Crossref | Medline32. Villar, J, Ferrando, C, Martínez, D, et al. (2020) Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. The Lancet. Respiratory medicine 8(3): 267–276. DOI: 10.1016/S2213-2600(19)30417-5.
Google Scholar | Crossref | Medline33. Zayed, Y, Barbarawi, M, Ismail, E, et al. (2020) Use of glucocorticoids in patients with acute respiratory distress syndrome: a meta-analysis and trial sequential analysis. Journal of Intensive Care 8: 43. DOI: 10.1186/s40560-020-00464-1.
Google Scholar | Crossref | Medline34. Lee, H-S, Lee, JM, Kim, MS, et al. (2005) Low-dose steroid therapy at an early phase of postoperative acute respiratory distress syndrome. The Annals of Thoracic Surgery 79(2): 405–410. DOI: 10.1016/j.athoracsur.2004.07.079.
Google Scholar | Crossref | Medline35. Rhodes, A, Evans, LE, Alhazzani, W, et al. (20162017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Critical care medicine 45(3): 486–552. DOI: 10.1097/CCM.0000000000002255.
Google Scholar | Crossref | Medline36. Annane, D, Sebille, V, Charpentier, C, et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288(7): 862–871. DOI: 10.1001/jama.288.7.862.
Google Scholar | Crossref | Medline | ISI37. Annane, D, Renault, A, Brun-Buisson, C, et al. (2018) Hydrocortisone plus fludrocortisone for adults with septic shock. New England Journal of Medicine 378(9): 809–818. DOI: 10.1056/NEJMoa1705716.
Google Scholar | Crossref | Medline38. Venkatesh, B, Finfer, S, Cohen, J, et al. (2018) Adjunctive glucocorticoid therapy in patients with septic shock. New England Journal of Medicine 378(9): 797–808. DOI: 10.1056/NEJMoa1705835.
Google Scholar | Crossref | Medline39. Sprung, CL, Annane, D, Keh, D, et al. (2008) Hydrocortisone therapy for patients with septic shock. New England Journal of Medicine 358(2): 111–124. DOI: 10.1056/NEJMoa071366.
Google Scholar | Crossref | Medline | ISI40. Volbeda, M, Wetterslev, J, Gluud, C, et al. (2015) Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis. Intensive Care Medicine 41(7): 1220–1234. DOI: 10.1007/s00134-015-3899-6.
Google Scholar | Crossref | Medline41. Annane, D, Bellissant, E, Bollaert, PE, et al. (2019) Corticosteroids for treating sepsis in children and adults. Cochrane Database of Systematic Reviews 2019: CD002243. DOI: 10.1002/14651858.CD002243.pub4.
Google Scholar | Crossref42. Fang, F, Zhang, Y, Tang, J, et al. (2019) Association of corticosteroid treatment with outcomes in adult patients with sepsis: a systematic review and meta-analysis. JAMA internal medicine 179(2): 213–223. DOI: 10.1001/jamainternmed.2018.5849.
Google Scholar | Crossref |

留言 (0)

沒有登入
gif